tera.ai

Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

All entities

Entity

ACR-368

product1 mentionslast seen Nov 6, 2026

Selective small molecule inhibitor targeting CHK1 and CHK2 in development for endometrial cancer.

Relationships 2

ACR-368

Relationship

Acrivon Therapeutics, Inc.developsACR-368

96% confidence1 supporting mentions

Either name opens that entity’s relationships.

Sources 1